3 months ago
RCEL
AnalystsRoss OsbornRoss Osborn's Stock Forecasts
AnalystsRoss Osborn
Analyst Ranking
Bottom 6%
#4345 out of 4577 analysts
Average Return
-13.69%
Win Rate
24%13 out of 55
Risk vs Reward
Poor
Good
Ross Osborn's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Elutia IncELUT | +132.00% | $1.25 | $2.90 | 2023-09-25 - 2024-05-07 | Strong Buy |
Nano X Imaging LtdNNOX | +81.16% | $5.36 | $9.71 | 2024-01-18 - 2024-05-07 | Strong Buy |
Elutia IncELUT | +77.91% | $1.63 | $2.90 | 2023-11-13 - 2024-05-07 | Strong Buy |
Elutia IncELUT | +75.76% | $1.65 | $2.90 | 2023-09-18 - 2024-05-07 | Strong Buy |
Neuropace IncNPCE | +69.43% | $7.85 | $13.30 | 2023-11-09 - 2024-05-07 | Strong Buy |
Ross Osborn Analyst Color
Get additional color on Ross Osborn's coverage of popular stocks
3 months ago
NYXH
a year ago
NNOX
Ross Osborn's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Cerus CorpCERS | 3 | Strong Buy | $4.00 | +116.22% | Maintains | 5 days ago |
Aspira Women's Health IncAWH | 5 | Hold | $3.30 | +11.86% | Reiterates | a month ago |
Prenetics Global LtdPRE | 5 | Strong Buy | $9.00 | +63.34% | Maintains | a month ago |
Lucid Diagnostics IncLUCD | 2 | Strong Buy | $3.00 | +191.26% | Maintains | a month ago |
Sanara Medtech IncSMTI | 3 | Strong Buy | $44.00 | +31.34% | Maintains | a month ago |
Volitionrx LtdVNRX | 2 | Strong Buy | $2.50 | +247.22% | Reiterates | a month ago |
Neuropace IncNPCE | 2 | Strong Buy | $18.00 | +35.34% | Maintains | 2 months ago |
Organogenesis Holdings IncORGO | 2 | Strong Buy | $5.00 | +104.92% | Reiterates | 2 months ago |
Si Bone IncSIBN | 7 | Strong Buy | $25.00 | +59.44% | Maintains | 2 months ago |
Avita Medical IncRCEL | 7 | Strong Buy | $25.00 | +166.81% | Maintains | 3 months ago |
Nano X Imaging LtdNNOX | 5 | Strong Buy | $18.00 | +85.38% | Reiterates | 3 months ago |
Nyxoah SaNYXH | 1 | Strong Buy | $14.00 | +55.04% | Maintains | 3 months ago |
Axogen IncAXGN | 2 | Strong Buy | $12.00 | +105.83% | Reiterates | 4 months ago |
Elutia IncELUT | 3 | Strong Buy | $6.00 | +106.90% | Maintains | 6 months ago |
Pacific Biosciences Of California IncPACB | 4 | Strong Buy | $11.00 | +488.24% | Upgrades | 6 months ago |
Exagen IncXGN | 3 | Strong Buy | $6.00 | +341.18% | Reiterates | 7 months ago |
Mainz Biomed NvMYNZ | 5 | Strong Buy | $9.00 | +1,047.96% | Reiterates | 7 months ago |
Asensus Surgical IncASXC | 2 | Strong Buy | $1.00 | +300.00% | Reiterates | 9 months ago |
Pavmed IncPAVM | 2 | Hold | $21.00 | +825.11% | Reiterates | 9 months ago |
Seaspine Holdings CorpSPNE | 1 | Strong Buy | $21.00 | N/A | Assumes | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.